Furthermore, the spliced form of XBP1 was previously shown to prevent β-amyloid neurotoxicity [17, 18], suggesting that selective activation of the IRE1α-XBP1s arm of the UPR may decrease the progression of AD. This evidence concerns the gene ERN1 and Alzheimer disease.